Buy Akcea Therapeutics Stock | AKCA Stock Price & Latest News | Public.com
AKCA

Akcea Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Akcea Therapeutics (AKCA) stock trends here

    About AKCA

    Akcea Therapeutics is a development and commercialization company focused on helping patients with serious diseases. Our priority is to drive clinical program execution, understand patient and physician needs, prepare the market, create market access, and commercialize ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.16
    -0.33
    -0.49
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.46

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,84B
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$21.70
    1 Year Low$8.00
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app